Risk factor
Very poor trading liquidity
Profitability factor
Very low or no dividends
About
Everest Organics Limited is a pharmaceutical enterprise specializing in the production of bulk drugs. Its product line encompasses compounds such as Omeprazole, Ciprofloxacin, Dichloroflurobenzene, and Benzimadizole. Additionally, the company manufactures and exports active pharmaceutical ingredients (APIs) and their intermediates from its facilities in India, supplying these to formulation companies worldwide. The firm was founded on February 19, 1993, and its headquarters are located in Hyderabad, India.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITD.